-
公开(公告)号:US3895114A
公开(公告)日:1975-07-15
申请号:US33360073
申请日:1973-02-20
Applicant: ABBOTT LAB
Inventor: JONES PETER HADLEY , MARTIN YVONNE CONNOLLY
IPC: A61K31/445 , A61K27/00
CPC classification number: A61K31/445
Abstract: Method of treating hypertension by administering to a hypertensive patient a therapeutically effective amount of a compound of the Formula
WHEREIN R1, R2, and R3 each are hydrogen, alkyl, cycloalkyl or aryl.Abstract translation: 通过向高血压患者施用治疗有效量的式WHEREIN R1,R2和R3的化合物各自为氢,烷基,环烷基或芳基的治疗高血压的方法。
-
公开(公告)号:US3901926A
公开(公告)日:1975-08-26
申请号:US44203474
申请日:1974-02-13
Applicant: ABBOTT LAB
Inventor: WINN MARTIN , LYNN KATHLEEN RILEY , MARTIN YVONNE CONNOLLY
IPC: C07C37/055 , C07D213/30 , C07D213/50 , C07D311/80 , C07D311/94 , C07D307/83
CPC classification number: C07D213/30 , C07C37/055 , C07D213/50 , C07D311/80 , C07D311/94 , C07C39/367
Abstract: Alkylphenyl benzopyrans represented by the formula
WHEREIN N IS 1 OR 2; EACH R and R1 are the same or different members of the group consisting of hydrogen or loweralkyl; R2 is loweralkyl; R3 is hydrogen; Y is a straight or branched chain alkylene group having from one to ten carbon atoms; and each R4 and R5 and R6 are the same or different members of the group consisting of hydrogen, halo, trifluoromethyl or loweralkyl and Z is C or N and the pharmaceutically acceptable salts thereof.-
公开(公告)号:US3903147A
公开(公告)日:1975-09-02
申请号:US40890273
申请日:1973-10-23
Applicant: ABBOTT LAB
Inventor: KYNCL JAROSLAV , RILEY KATHLEEN , MARTIN YVONNE CONNOLLY , OURS CARROLL WAYNE
IPC: C07C237/00 , C07C103/50
CPC classification number: C07C237/00
Abstract: Covers a gamma -glutamyl amide of dopamine selected from the group consisting of
and a pharmaceutically acceptable acid addition salt thereof. Also covers the use of said gamma -glutamyl amide to increase renal blood flow by administering said amide to warm-blooded mammals.Abstract translation: 覆盖选自HO | HO-CH 2 -CH 2 -NH 2 | PARALLEL C-CH 2 -CH 2 -CH-C-OH平行| ONH 2的多巴胺的γ-谷氨酰胺及其药学上可接受的酸加成盐。 还涵盖了通过将所述酰胺施用于温血哺乳动物来增加所述γ-谷氨酰胺以增加肾血流量的用途。
-
-